IPQ Inside the global regulatory dialogue

CBER’s Compliance Office Absorbing Impact of Cell/Gene Therapy Wave in its Pre-Market and Surveillance Operations

Nov 20th, 2018

Please Log in to print the full article

Lot Release Program Demands Also Expanding Also adding to OCBQ’s workload is a large increase in the number of lots that come through CBER under its lot release program. Malarkey noted that the number had...

You must be a paid subscriber to continue reading this article. If you are a paid subscriber, please Log in. If you are not a paid subscriber, please subscribe now.

©2021 IPQ Publications